Pentwater Capital Management LP Pure Tech Health PLC Transaction History

Pentwater Capital Management LP

$9.58 Billion
Q3 2024

A detailed history of Pentwater Capital Management LP transactions in Pure Tech Health PLC stock. As of the latest transaction made, Pentwater Capital Management LP holds 25,000 shares of PRTC stock, worth $507,250. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,000

Previous 16,193 54.39%

Holding current value

$507,250

Previous $404,000 28.47%

% of portfolio

0.01%

Previous 0.01%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.42 - $25.0 $171,031 - $220,175	8,807 Added 54.39%	25,000 $519,000
Q2 2024 Jul 31, 2024	SELL	$23.78 - $32.98 $19,190 - $26,614	-807 Reduced 4.75%	16,193 $404,000
Q1 2024 May 15, 2024	BUY	$22.05 - $29.4 $148,969 - $198,626	6,756 Added 65.95%	17,000 $484,000
Q4 2023 Feb 14, 2024	BUY	$17.08 - $28.18 $174,967 - $288,675	10,244 New	10,244 $288,000

Others Institutions Holding PRTC

# of Institutions

Shares Held

28.7K

Call Options Held

Put Options Held

View Full List

About PureTech Health plc

Ticker PRTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,888,500
Market Cap $566M
Description
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...

More about PRTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Account

Pentwater Capital Management LP Pure Tech Health PLC Transaction History